Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2025-01-31

New combination of medicines to treat parasitic worm infections

View source ↗

Summary

EMA issued an opinion endorsing the use of a combination of ivermectin and albendazole to treat parasitic worm infections as part of global elimination efforts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)
  • IVERMECTIN (Ivermectin)

Snippet

EMA opinion for ivermectin and albendazole supports global efforts to eliminate widespread infections